Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Health Bulletin 6/September/2022

admin by admin
September 6, 2022
in Pharmaceutical


Here are the top health news for the day:

46 Doctors honored with IMA honorary professorship on teachers day

46 doctors across the country were titled honorary Professors of IMA for their contribution to the professional development program of the IMA in a recently held ceremony observing Teachers Day here. The doctors were conferred these awards by Union Health Minister Dr. Mansukh Mandaviya.

The special event was inaugurated by the Chief Guest, Dr. Mansukh Mandaviya, Hon’ble Minister of Health & Family Welfare, GoI, in the presence of Shri Pashupati Kumar Paras, Hon’ble Minister of Food Processing Industries, GoI, and Mrs. Meenakshi Lekhi, Hon’ble Minister of State of External Affairs, GoI who were the Guest of Honor.

For more details, check out the link given below:

46 Doctors honored with IMA honorary professorship on Teachers day

NMC declares conversion therapy as professional misconduct under IMC regulations

Complying with the directions issued by the Madras High Court, the National Medical Commission (NMC) has recently notified about enlisting “Conversion Therapy” as professional misconduct under the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2022.

Writing to the State Medical Councils in this regard, the Ethics and Medical Registration Board (EMRB) of NMC stated, “In compliance of the order dated 8th July, 2022, Ethics and Medical Registration Board, National Medical Commission has decided that Conversion therapy will constitute a professional misconduct under the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2022.”

For more details, check out the link given below:

NMC declares conversion therapy as professional misconduct under IMC regulations

Govt fee for 50 percent MBBS seats in private medical colleges, universities: Supreme Court to decide

The validity of the National Medical Commission’s fee order making the fee of 50 percent seats in Private Medical Colleges & Deemed Universities at par with Government Medical Colleges would now be decided by the Supreme Court, which has already issued notice in the matter.

While considering the plea filed by Association Of Health Sciences Institutes (AHSI), the top court bench comprising of Justices DY Chandrachud and Hima Kohli on Monday has granted the National Medical Commission (NMC) two weeks’ time for filing a counter affidavit in this regard.

For more details, check out the link given below:

Govt fee for 50 percent MBBS seats in private medical colleges, universities: Supreme Court to decide

FIRST: CanSino Biologics inhaled COVID vaccine gets Chinese emergency use nod as booster

China’s CanSino Biologics Inc has announced that its recently developed COVID-19 vaccine has been approved by the country’s drug regulator for emergency use as a booster, potentially benefiting its business.

The inhaled version of Cansino’s adenovirus-vectored COVID-19 vaccine has obtained the green light from the National Medical Products Administration, the company said in a filing on Sunday.

For more details, check out the link given below:

FIRST: CanSino Biologics inhaled COVID vaccine gets Chinese emergency use nod as booster



Source link

Tags: Association Of Health Sciences InstitutesCanSino BiologicsCanSino Biologics newsConversion TherapycoronavirusCoronavirus Vaccinecovid-19doctorDr Mansukh MandaviyaDY ChandrachudEthics and Medical Registration BoardHima KohliIMAIndian Medical AssociationIndian Medical Council regulationsinhaled COVID vaccineMadras High CourtMBBSMBBS seatsmedical collegeNational Medical CommissionNMCprivate medical collegeSupreme Courtteachers day
Previous Post

Data Reveal Growing Burden of Metastatic Cancers in the US

Next Post

FDA holds rare second meeting over an ALS drug

Next Post

FDA holds rare second meeting over an ALS drug

Recommended

AAD Updates Guidelines for Topical AD Treatment in Adults

January 15, 2023

Orserdu Approved for ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

January 31, 2023

Don't miss it

Pharmaceutical

ALS Association battles its chapters over money, priorities

February 3, 2023
Medicines & Healthy Lifestyle

Surgery and Prescriptions Now Advised for Obese Children?

February 3, 2023
Medicines & Healthy Lifestyle

Jesduvroq Approved for Anemia of CKD in Patients on Dialysis

February 3, 2023
Medicines & Healthy Lifestyle

Prescribing Medication Dosage According To DNA Profile Lowers Side Effects By 30%: Study

February 3, 2023
News

Longer Diabetes Duration Links With Increased Heart Failure

February 3, 2023
Pharmaceutical

Health Bulletin 3/ February/ 2023

February 3, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.